Gomes, Lauren et al "Upper gastrointestinal tract lymphoma with Natalizumab: Evidence of impaired immune surveillance?." Neurology: Clinical Practice (2020): 10.1212/CPJ.0000000000000985. Web. 26 Jan. 2021.